Literature DB >> 27356490

Validation of new renal staging system in AL amyloidosis treated with high dose melphalan and stem cell transplantation.

Andrea Havasi1,2, Lauren Stern1,2, Stephen Lo2, Fangui Sun3, Vaishali Sanchorawala4,5.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27356490      PMCID: PMC5031518          DOI: 10.1002/ajh.24464

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  6 in total

1.  Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients.

Authors:  Maria Teresa Cibeira; Vaishali Sanchorawala; David C Seldin; Karen Quillen; John L Berk; Laura M Dember; Adam Segal; Frederick Ruberg; Hans Meier-Ewert; Nancy T Andrea; J Mark Sloan; Kathleen T Finn; Gheorghe Doros; Joan Blade; Martha Skinner
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

2.  Incidence and outcome of acute renal failure complicating autologous stem cell transplantation for AL amyloidosis.

Authors:  Amit Fadia; Liam F Casserly; Vaishali Sanchorawala; David C Seldin; Daniel G Wright; Martha Skinner; Laura M Dember
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

Review 3.  Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

Authors:  Morie A Gertz; Ray Comenzo; Rodney H Falk; Jean Paul Fermand; Bouke P Hazenberg; Philip N Hawkins; Giampaolo Merlini; Philippe Moreau; Pierre Ronco; Vaishali Sanchorawala; Orhan Sezer; Alan Solomon; Giles Grateau
Journal:  Am J Hematol       Date:  2005-08       Impact factor: 10.047

4.  A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis.

Authors:  Giovanni Palladini; Ute Hegenbart; Paolo Milani; Christoph Kimmich; Andrea Foli; Anthony D Ho; Marta Vidus Rosin; Riccardo Albertini; Remigio Moratti; Giampaolo Merlini; Stefan Schönland
Journal:  Blood       Date:  2014-08-12       Impact factor: 22.113

5.  The impact of dialysis on the survival of patients with immunoglobulin light chain (AL) amyloidosis undergoing autologous stem cell transplantation.

Authors:  Nelson Leung; Shaji K Kumar; Siobhan V Glavey; Angela Dispenzieri; Martha Q Lacy; Francis K Buadi; Suzanne R Hayman; David Dingli; Prashant Kapoor; Steven R Zeldenrust; Stephen J Russell; John A Lust; William J Hogan; S Vincent Rajkumar; Dennis A Gastineau; Taxiarchis V Kourelis; Yi Lin; Wilson I Gonsalves; Ronald S Go; Morie A Gertz
Journal:  Nephrol Dial Transplant       Date:  2015-11-30       Impact factor: 5.992

6.  Renal risk and response in amyloidosis.

Authors:  Angela Dispenzieri
Journal:  Blood       Date:  2014-10-09       Impact factor: 22.113

  6 in total
  4 in total

1.  Predictive value of the new renal response criteria in AL amyloidosis treated with high dose melphalan and stem cell transplantation.

Authors:  Andrea Havasi; Gheorghe Doros; Vaishali Sanchorawala
Journal:  Am J Hematol       Date:  2018-02-24       Impact factor: 10.047

2.  The utility of repeat kidney biopsy in systemic immunoglobulin light chain amyloidosis.

Authors:  Avital Angel-Korman; Aala Jaberi; Vaishali Sanchorawala; Andrea Havasi
Journal:  Amyloid       Date:  2019-10-09       Impact factor: 7.141

3.  Correlation Between 24-Hour Urine Protein and Random Urine Protein-Creatinine Ratio in Amyloid Light-Chain Amyloidosis.

Authors:  Lisa Mendelson; Vaishali Sanchorawala; Lawreen Connors; Tracy Joshi; Gheorghe Doros; Alexander Pogrebinsky; Andrea Havasi
Journal:  Kidney Med       Date:  2022-02-03

4.  Outcomes of renal transplantation in patients with AL amyloidosis: an international collaboration through The International Kidney and Monoclonal Gammopathy Research Group.

Authors:  Andrea Havasi; Cihan Heybeli; Nelson Leung; Avital Angel-Korman; Vaishali Sanchorawala; Oliver Cohen; Ashutosh Wechalekar; Frank Bridoux; Insara Jaffer; Victoria Gutgarts; Hani Hassoun; Maya Levinson; Cara Rosenbaum; Paolo Milani; Giovanni Palladini; Giampaolo Merlini; Ute Hegenbart; Stefan Schönland; Kaya Veelken; Alexander Pogrebinsky; Gheorghe Doros; Heather Landau
Journal:  Blood Cancer J       Date:  2022-08-18       Impact factor: 9.812

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.